Dyadic International Correlations
DYAI Stock | USD 1.00 0.01 1.01% |
The current 90-days correlation between Dyadic International and Anebulo Pharmaceuticals is 0.37 (i.e., Weak diversification). The correlation of Dyadic International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Dyadic International Correlation With Market
Weak diversification
The correlation between Dyadic International and DJI is 0.31 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and DJI in the same portfolio, assuming nothing else is changed.
Dyadic |
Moving together with Dyadic Stock
0.78 | MOLN | Molecular Partners | PairCorr |
0.81 | NBIX | Neurocrine Biosciences | PairCorr |
0.76 | PASG | Passage Bio | PairCorr |
0.77 | PRLD | Prelude Therapeutics | PairCorr |
0.61 | ANIP | ANI Pharmaceuticals | PairCorr |
0.62 | ANTX | AN2 Therapeutics | PairCorr |
0.63 | STTK | Shattuck Labs | PairCorr |
0.67 | BDTX | Black Diamond Therap | PairCorr |
Moving against Dyadic Stock
0.79 | ZTS | Zoetis Inc | PairCorr |
0.78 | GILD | Gilead Sciences | PairCorr |
0.69 | BMY | Bristol Myers Squibb | PairCorr |
0.66 | PAHC | Phibro Animal Health | PairCorr |
0.6 | FHTX | Foghorn Therapeutics | PairCorr |
0.51 | BHC | Bausch Health Companies | PairCorr |
0.48 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.36 | KYMR | Kymera Therapeutics | PairCorr |
0.35 | PHVS | Pharvaris BV | PairCorr |
0.31 | GLUE | Monte Rosa Therapeutics | PairCorr |
0.74 | ICUI | ICU Medical | PairCorr |
0.73 | MMSI | Merit Medical Systems | PairCorr |
0.67 | COLL | Collegium Pharmaceutical | PairCorr |
0.59 | NUTX | Nutex Health | PairCorr |
0.58 | PETQ | PetIQ Inc | PairCorr |
0.54 | ABBV | AbbVie Inc | PairCorr |
0.43 | RZLT | Rezolute | PairCorr |
0.39 | CVS | CVS Health Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Dyadic Stock performing well and Dyadic International Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Dyadic International's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
HOWL | 4.50 | (0.19) | 0.00 | 0.03 | 5.40 | 8.33 | 38.18 | |||
EWTX | 4.24 | 0.67 | 0.19 | 0.39 | 3.70 | 7.67 | 61.02 | |||
DBTX | 3.74 | 0.45 | 0.06 | (0.58) | 4.12 | 7.85 | 26.09 | |||
CELC | 2.41 | (0.22) | 0.00 | (0.07) | 0.00 | 4.95 | 17.55 | |||
CCCC | 4.21 | 0.06 | 0.07 | 0.13 | 4.18 | 12.87 | 23.76 | |||
ANEB | 5.26 | (0.22) | (0.01) | 0.02 | 6.92 | 9.09 | 76.00 | |||
PMVP | 1.85 | (0.13) | (0.04) | (0.01) | 2.32 | 3.87 | 12.32 | |||
ANTX | 3.27 | (1.05) | 0.00 | (0.52) | 0.00 | 6.88 | 69.81 | |||
ELYM | 4.12 | (0.20) | 0.00 | 0.27 | 0.00 | 9.09 | 34.87 | |||
HCWB | 5.51 | 0.01 | 0.00 | 0.10 | 0.00 | 11.90 | 46.43 |
Dyadic International Corporate Management
Ronen Tchelet | VP of Bus. Devel. for Europe | Profile | |
Joseph Hazelton | Chief Officer | Profile | |
Doug BA | Executive Development | Profile | |
Ana Rodriguez | Secretary Board | Profile |